GILD
<% (signals.list.current.rate).substr(0,7) %>
<% signal.analyst %>
Last Updated: Jun 17, 2026 03:20:48 PM (GMT)
GILD: The current market price is 127.39, reflecting a minor increase of +0.17% from the previous price.
Support and Resistance Levels Current support levels are 127.17, 127.17, 127.17, while resistance levels are also at 127.17, 127.17, 127.17. The pivot point stands at 127.17.
Indicators RSI is at 70.74, indicating market overbought conditions. The ATR is currently 0.19425, suggesting relatively low volatility. Parabolic SAR has flipped, signaling a potential bullish trend. The MACD shows a histogram at -0.10066, indicating bearish momentum. The 5-day SMA is at 127.17, aligning with the pivot point.
Market Sentiment Since the price is above the pivot point of 127.17, alongside bullish indicators, the market suggests a bullish scenario.
GILD Signals & Technical Analysis
Market Sentiment
Trend Indicators
Oscillators
Moving Averages
Pivot
About (gild) Gilead Sciences, Inc.
Gilead Sciences, Inc. (NASDAQ: GILD) is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need. Founded in 1987 and headquartered in Foster City, California, Gilead has established itself as a leader in the development of antiviral drugs that combat HIV, hepatitis B and C, influenza, and COVID-19. With a commitment to advancing global health, Gilead's research and development efforts focus on creating transformative medicines for patients worldwide.
Over the years, Gilead has built a strong market position, particularly in the field of antiviral therapies. The company gained widespread recognition for its groundbreaking treatments, including the antiretroviral therapy Truvada, which has played a crucial role in combating the HIV epidemic. Additionally, Gilead's innovative approach to hepatitis C treatment, notably with its drug Harvoni, revolutionized care practices and significantly reduced the disease's prevalence. As of 2023, Gilead continues to strengthen its presence in the market with robust pipelines that encompass other therapeutic areas, including oncology and inflammation.
In terms of financial performance, Gilead Sciences has demonstrated resilience amidst a dynamic healthcare landscape. The company reported a revenue of $27 billion for the fiscal year 2022, reflecting a steady demand for its key products despite emerging competition. Gilead's strategic investments in research and development have positioned it for sustained growth, with an R&D expenditure exceeding $5 billion in the same year. This commitment underscores Gilead's focus on innovation and its ability to adapt to changing healthcare needs.
Gilead Sciences is also recognized for its global initiatives aimed at expanding access to its therapies, particularly in low- and middle-income countries. The company's partnerships with various organizations, including governments and non-profits, highlight its dedication to improving health outcomes worldwide. As Gilead continues to evolve, it remains committed to delivering cutting-edge solutions that enhance the quality of life for patients everywhere.
How to Buy or Trade Gilead Sciences, Inc. Stock (GILD) with AvaTrade
Trading or investing in Gilead Sciences, Inc. stock through AvaTrade starts with opening a verified trading account. After registration, complete the KYC verification process by submitting your ID and proof of address, then fund your account using a supported payment method such as bank transfer, debit card, or e-wallet. Once your funds reflect, log into the AvaTrade platform or mobile app and search for the ticker symbol GILD, which represents Gilead Sciences, Inc.. Before placing a trade, review the live Gilead Sciences, Inc. share price, market trend, spread, leverage options, and recent market news that could impact the stock price.
The next step is deciding whether you want to buy or sell Gilead Sciences, Inc. stock. Traders expecting the price to rise typically open a Buy position, while traders expecting weakness in the sector may open a Sell position using CFDs. Enter your preferred trade size, then apply risk management tools such as a stop-loss to limit downside exposure and a take-profit order to secure profits automatically. After confirming the trade, monitor key drivers including Gilead Sciences, Inc. earnings reports, product or service announcements, business segment performance, revenue growth, and overall stock market sentiment. Many traders also use technical indicators such as moving averages, RSI, and support/resistance levels available on the AvaTrade platform to improve timing and trading decisions.
Related Stocks
Sidebar rates
- <% signal.pair %>
<% signals.active.Current.rate.substr(0,7) %>
